abagovomab 7
abciximab 18
abituzumab 5
abrilumab 12
actoxumab 6
adalimumab 9
aducanumab 5
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 18
alirocumab 7
amatuximab 14
andecaliximab 9
anifrolumab 7
anrukinzumab 10
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 6
ascrinvacumab 0
atezolizumab 9
atinumab 9
avelumab 6
basiliximab 9
bavituximab 8
begelomab 6
benralizumab 9
bevacizumab_beta 10
bezlotoxumab 6
bimagrumab 8
bleselumab 5
blinatumomab 15
blosozumab 19
bococizumab 14
brazikumab 7
brentuximab_vedotin 10
briakinumab 6
brodalumab 3
brolucizumab 14
brontictuzumab 13
burosumab 12
cabiralizumab 7
camrelizumab 4
canakinumab 12
cantuzumab_ravtansin 19
carlumab 11
carotuximab 7
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 16
cetiximab 23
citatuzumab_bogatox 20
cixutumumab 12
clivatuzumab_tetraxetan 10
codrituzumab 18
conatumumab 8
concizumab 12
crenezumab 9
crizanlizumab 10
crotedumab 16
dacetuzumab 20
daclizumab 5
dalotuzumab 16
dapirolizumab_pegol 16
daratumumab 10
dectrekumab 3
demcizumab 14
denosumab 7
depatuxizumab 11
depatuxizumab_mafodotin 11
dezamizumab 3
dinutuximab 21
diridavumab 4
domagrozumab 5
drozitumab 4
duligotuzumab 14
durvalumab 0
dusigitumab 5
efalizumab 22
efungumab 9
eldelumab 6
elezanumab 9
elgemtumab 3
elotuzumab 6
emactuzumab 11
emapalumab 11
emibetuzumab 8
enavatuzumab 19
enfortumab_vedotin 6
enoblituzumab 10
enokizumab 14
enoticumab 9
ensituximab 10
eptinezumab 8
erenumab 7
etaracizumab 12
etrolizumab 18
evinacumab 13
evolocumab 3
farletuzumab 0
fasinumab 13
fezakinumab 6
fibatuzumab 0
ficlatuzumab 12
firivumab 19
flanvotumab 4
fletikumab 14
foralumab 4
foravirumab 11
fremanezumab 13
fresolimumab 10
fulranumab 13
futuximab 8
galcanezumab 7
ganitumab 13
gantenerumab 3
gemetuzumab 14
gemtuzumab2 18
gemtuzumab 8
gevokizumab 14
girentuximab 16
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 11
ibalizumab 11
ibritumomab 10
icrucumab 6
idarucizumab 14
ifabotuzumab 0
imalumab 11
imgatuzumab 10
inclacumab 10
indatuximab_ravtansin 16
indusatumab 6
inebilizumab 13
intetumumab 3
iodine_girentuximab 18
ipilimumab 0
iratumumab 4
isatuximab 9
itolizumab 15
ixekizumab 14
labetuzumab_govitecan 13
lambrolizumab 11
lampalizumab 13
lanadelumab 15
landogrozumab 9
laprituximab 15
lebrikizumab 18
lendalizumab 19
lenzilumab 6
lifastuzumab_vedotin 15
ligelizumab 7
lilotomab 15
lirilumab 11
lodelcizumab 12
lokivetmab 11
lorvotuzumab_mertansin 4
lucatumumab 19
lumretuzumab 6
lupartumab 6
lutikizumab 9
margetuximab 21
milatuzumab 14
mirvetuximab 18
mirvetuximab_soravtansin 18
modotuximab 22
mogamulizumab 17
monalizumab 12
motavizumab 19
moxetumomab_pasudotox 14
namilumab 8
naratuximab 13
naratuximab_emtansin 13
narnatumab 8
navicixizumab2 16
navicixizumab 14
navivumab 7
necitumumab 3
nemolizumab 13
nesvacumab 11
nivolumab 7
obiltoxaximab 11
obinutuzumab 21
ocaratuzumab 12
ofatumumab 9
olaratumab 8
olokizumab 19
omalizumab 15
onartuzumab 12
ontuxizumab 8
opicinumab 13
orticumab 6
otelixizumab 17
oxelumab 6
ozanezumab 10
pamrevlumab 3
panobacumab 11
parsatuzumab 19
pasotuxizumab 16
pateclizumab 9
patritumab 9
pembrolizumab 11
perakizumab 15
pidilizumab 8
pinatuzumab_vedotin 8
plozalizumab 8
pogalizumab 9
polatuzumab_vedotin 13
ponezumab 15
prezalumab 10
pritoxaximab 16
quilizumab 11
racotumomab 15
radretumab 7
ralpancizumab 19
ramucirumab 7
ranevetmab 22
ranibizumab 7
refanezumab 13
remtolumab 10
rilotumumab 6
rinucumab 3
risankizumab 20
rituximab 3
rivabazumab 12
robatumumab 18
roledumab 9
romosozumab 10
rontalizumab 13
rosmantuzumab 10
rozanolixizumab 11
sacituzumab 14
sacituzumab_govitecan 14
samalizumab 14
sapelizumab 13
sarilumab 6
secukinumab 6
seribantumab 13
setoxaximab 23
sifalimumab 0
siltuximab 7
simtuzumab 14
sirukumab 8
solanezumab 21
solitomab 5
stamulumab 11
suptavumab 17
suvizumab 5
tabalumab 0
tadocizumab 4
tamtuvetmab 21
tanezumab 13
tarextumab 5
tavolixizumab 7
telisotuzumab 15
teplizumab 8
tesidolumab 7
tezepelumab 12
tigatuzumab 12
tildrakizumab 8
timolumab 6
tisotumab 5
tosatoxumab 16
tositumomab 10
tralokinumab 16
trastuzumab 19
tregalizumab 17
trevogrumab 7
ublituximab 12
urelumab 9
ustekinumab 17
utomilumab 14
vadastuximab 9
vadastuximab_talirin 9
vandortuzumab_vedotin 8
vantictumab 11
vanucizumab2 10
vanucizumab 8
varlilumab 12
vatelizumab 8
vedolizumab 3
veltuzumab 0
vesencumab 4
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 18
xentuzumab 10
zatuximab 22
